• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News  
Title Created Date
Why you should not use the journal impact factor to evaluate research 12 January 2014
Declaration recommends eliminate the use of Impact factor for research evaluation 10 January 2014
Display # 

Search

Follow us...

Latest

  • Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives
  • From molecular basis to clinical insights: a challenging future for the vitamin D endocrine system in colorectal cancer
  • Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect
  • Protective effects of exogenous melatonin therapy against oxidative stress to male reproductive tissue caused by anti-cancer chemical and radiation therapy: a systematic review and meta-analysis of animal studies
  • Melatonin Prevents Depression but Not Anxiety-like Behavior Produced by the Chemotherapeutic Agent Temozolomide: Implication of Doublecortin Cells and Hilar Oligodendrocytes
  • Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience
  • Resolution of thymoma-related pure red cell aplasia after octreotide treatment
  • Of sight, and insight into melatonin’s role in breast cancer?
  • Melatonin modulates tumor metabolism and mitigates metastasis
  • Structural Elements Directing G Proteins and β-Arrestin Interactions with the Human Melatonin Type 2 Receptor Revealed by Natural Variants
  • Structure and function of a dual antagonist of the human growth hormone and prolactin receptors with site-specific PEG conjugates
  • Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats
  • Efficacy, mechanism, and safety of melatonin-loaded on thermosensitive nanogels for rabbit VX2 tumor embolization: A novel design
  • Melatonin modulates metabolic adaptation of pancreatic stellate cells subjected to hypoxia
  • Melatonin and andrographolide synergize to inhibit the colospheroid phenotype by targeting Wnt/beta-catenin signaling
  • Melatonin enhances anti-tumor immunity by targeting macrophages PD-L1 via exosomes derived from gastric cancer cells
  • A meta-analysis of microRNA networks regulated by melatonin in cancer: Portrait of potential candidates for breast cancer treatment
  • PDIA3 modulates genomic response to 1,25-dihydroxyvitamin D3 in squamous cell carcinoma of the skin

Most Read

  • The Di Bella Method (DBM)
  • All-trans-retinoic acid and cancer
  • About melatonin - 1996
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • How effective is chemo therapy?
  • Vademecum
  • Frequently Asked Questions
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients